Carregant...
Outcomes of autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma refractory to first line chemoimmunotherapy
Outcomes of patients with primary refractory diffuse large B cell lymphoma (DLBCL) are dismal. The role of autologous hematopoietic cell transplant (autoHCT) in this population is not well defined in the modern era. Most datasets combine these patients with those with relapsed disease. We report the...
Guardat en:
| Publicat a: | Transplant Cell Ther |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965782/ https://ncbi.nlm.nih.gov/pubmed/32949754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.09.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|